EXOZ
eXoZymes, Inc.
NASDAQ: EXOZ · HEALTHCARE · BIOTECHNOLOGY
$9.98
-3.57% today
Updated 2026-04-30
Market cap
$87.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$7 – $18
Volume
0.0M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.05M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $-700.00 |
| Net income | $-1.40M | $-2.04M | $-5.86M | $-9.16M | $-2.66M |
| EPS | — | — | — | — | $-1.09 |
| Free cash flow | $-1.44M | $-1.47M | $-8.90M | $-6.67M | $-2.05M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
eXoZymes, Inc. trades at $9.98. Our Smart Value Score of 16/100 indicates the stock is weak. TTM revenue stands at $-700.00.
Frequently asked questions
What is eXoZymes, Inc.'s stock price?
eXoZymes, Inc. (EXOZ) trades at $9.98.
Is eXoZymes, Inc. overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of eXoZymes, Inc. (EXOZ)?
The analyst target price is $—, representing NaN% downside from the current price of $9.98.
What is eXoZymes, Inc.'s revenue?
TTM revenue is $-700.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-132.60%
Beta—
50D MA$8.83
200D MA$11.27
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—